Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Febit Achieves Sales Goals

Published: Thursday, March 16, 2006
Last Updated: Monday, March 27, 2006
Bookmark and Share
Febit successfully markets the GENIOM bioanalysis device.

Febit biotech gmbh has announced that it has successfully concluded the business year, meeting its sales goals for 2005.

Sales of GENIOM™, a biochip-driven nucleic acid analysis system, were on budget already in the year of Febit's re-establishment.

This development is based on the fundamental restructuring and re-establishment of Febit biotech gmbh in spring 2005 when the company moved into new quarters in the Heidelberg Technologiepark.

Since its reorganization, Febit is supported by Dietmar and Oliver Hopp, two experienced biotech investors interested in a favourable long-term development of the company.

Integrating its structural and financial basis, Febit's re-establishment was supported by Prof. Christof Hettich, an experienced consultant from the Rittershaus firm of Mannheim.

In October 2005 the management team around Cord F. Stahler, CEO of Febit biotech gmbh was expanded, a supervisory board was established and the headcount was gradually increased.

The team consisting of management, staff and supervisory board boasts know-how and skills in all relevant areas. 

Febit has become a valuable cooperation partner in the biotech field, which is illustrated by a number of licence agreements signed in late 2005.

From Oxford Gene Technology, Febit acquired a license for the southern array technique, a method of major impact in gene research, thus enhancing its position with respect to intellectual property on the global market.

In a license agreement with the German Cancer Reseach Center (DKFZ), Febit acquired the rights to an alternative high-efficacy DNA synthesis method for use in its GENIOM® platform.       

Dr. Jorg Hoheisel at the DKFZ strongly supports the GENIOM® platform, said, "This DNA analysis device offers tremendous flexibility and has an extraordinary potential. It is invaluable for many aspects of our work at the DKFZ."   

The product website went online recently, complementing the corporate website and broadening Febit´s internet information resources for customers, investors and the public.

In February 2005, the Febit facilities were substantially enlarged and the headcount will reach 50 at the end of 2006 in order to realize the expansion plans and to ensure reliable product quality and availability. 

Cord F. Stahler, Chief Executive Officer of Febit biotech gmbh is confident to generate substantial growth within 2006, "The changes we made in 2005 and our network allow us to rapidly expand our position on the international market."

"The global market of DNA analysis devices will keep growing substantially in the next years. Febit will participate in this growth due to significant product advantages and the market-readiness of GENIOM®."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Geniom Technology Applied to Targeted Next-Generation Sequencing
By enabling selective targeting, the Geniom® Biochip will allow researchers to sequence individual and well defined parts of genomes
Tuesday, July 24, 2007
Febit Establishes US Company
Febit launches the GENIOM biochip system in the US.
Tuesday, August 15, 2006
Scientific News
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Biologists Induce Flatworms to Grow Heads and Brains of Other Species
Findings shed light on role of a new kind of epigenetic signaling in evolution, could yield clues for understanding birth defects and regeneration.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
The Secret Behind the Power of Bacterial Sex
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
Farming’s in Their DNA
Ancient genomes reveal natural selection in action.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos